Unseen Biometrics ApS — Credit Rating and Financial Key Figures
CVR number: 40046585
Fruebjergvej 3, 2100 København Ø
support@unseenbio.com
tel: 26131426
unseenbio.com
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -14.46 | 1 179.58 | - 319.00 | -1 810.00 | -1 529.49 |
| Employee benefit expenses | - 625.00 | -1 943.00 | -2 906.26 | ||
| Total depreciation | - 532.83 | ||||
| EBIT | -14.46 | 1 179.58 | - 944.00 | -3 753.00 | -4 968.59 |
| Other financial income | 13.11 | ||||
| Other financial expenses | -0.10 | -4.00 | - 256.00 | - 484.56 | |
| Pre-tax profit | -14.46 | 1 179.48 | - 948.00 | -4 009.00 | -5 440.04 |
| Income taxes | 0.81 | - 188.69 | 267.00 | - 149.60 | |
| Net earnings | -13.64 | 990.79 | - 681.00 | -4 009.00 | -5 589.65 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 140.28 | 1 212.96 | 2 088.00 | 3 730.00 | 4 671.57 |
| Intangible assets total | 140.28 | 1 212.96 | 2 088.00 | 3 730.00 | 4 671.57 |
| Tangible assets total | |||||
| Other receivables | 23.36 | 29.91 | 30.00 | 71.00 | 70.78 |
| Investments total | 23.36 | 29.91 | 30.00 | 71.00 | 70.78 |
| Long term receivables total | |||||
| Raw materials and consumables | 158.00 | 174.80 | |||
| Inventories total | 158.00 | 174.80 | |||
| Current trade debtors | 191.88 | 143.00 | 1 131.00 | 319.16 | |
| Current other receivables | 12.25 | 375.00 | 28.00 | 24.07 | |
| Current deferred tax assets | 30.86 | 47.30 | 193.00 | 361.00 | 324.41 |
| Short term receivables total | 43.12 | 614.18 | 336.00 | 1 520.00 | 667.64 |
| Cash and bank deposits | 51.82 | 693.74 | 74.00 | 997.00 | 2 692.37 |
| Cash and cash equivalents | 51.82 | 693.74 | 74.00 | 997.00 | 2 692.37 |
| Balance sheet total (assets) | 258.57 | 2 550.79 | 2 528.00 | 6 476.00 | 8 277.15 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 140.00 | 147.18 | 147.00 | 170.00 | 201.03 |
| Other reserves | 109.42 | 946.11 | 946.00 | 2 227.00 | 3 643.82 |
| Retained earnings | - 109.42 | - 216.93 | 774.00 | 1 993.00 | 2 486.80 |
| Profit of the financial year | -13.64 | 990.79 | - 681.00 | -4 009.00 | -5 589.65 |
| Shareholders equity total | 126.36 | 1 867.15 | 1 186.00 | 381.00 | 742.00 |
| Provisions | 30.05 | 266.04 | 193.00 | 554.00 | 1 027.74 |
| Non-current loans from credit institutions | 3 134.00 | 3 558.71 | |||
| Non-current liabilities total | 3 134.00 | 3 558.71 | |||
| Advances received | 1 818.00 | 2 597.10 | |||
| Current trade creditors | 1.25 | 130.50 | 67.00 | 331.00 | 147.97 |
| Current owed to participating | 100.00 | 200.00 | 200.00 | ||
| Other non-interest bearing current liabilities | 0.92 | 87.11 | 882.00 | 258.00 | 203.61 |
| Current liabilities total | 102.17 | 417.60 | 1 149.00 | 2 407.00 | 2 948.68 |
| Balance sheet total (liabilities) | 258.57 | 2 550.79 | 2 528.00 | 6 476.00 | 8 277.15 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.